The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase I dose-escalation study of intratumoral herpes simplex virus-1 mutant HSV1716 in pediatric/young adult patients with refractory non-central nervous system solid tumors.
Timothy P. Cripe
No relevant relationships to disclose
John M Racadio
No relevant relationships to disclose
Joe Conner
Employment or Leadership Position - Virttu Biologics
Alexander Towbin
No relevant relationships to disclose
Marianne M Brunner
No relevant relationships to disclose
Beth A Stockman
No relevant relationships to disclose
Mark Currier
No relevant relationships to disclose
James I. Geller
No relevant relationships to disclose